Physician

Urology

Bruce A. Lowe practices Urology. He attended University of Kansas School of Medicine. He received 2 awards: "Portland Monthly Magazine" and "Top MD". Bruce Lowe is also a published doctor. He has 46 publication published. The most recent publication is: Bilateral orchiectomy with or without flutamide for metastatic prostate cancer.

Publications

---

• Randomized study of high-dose pulse calcitriol or placebo prior to radical Prostatectomy.
• Phase I study of weekly mitoxantrone and docetaxel before prostatectomy in patients with high-risk localized prostate Cancer.
• High-dose weekly oral calcitriol in patients with a rising PSA after Prostatectomy or radiation for Prostate carcinoma.
• Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate Cancer.
• Neoadjuvant therapy before radical Prostatectomy for clinical T3/T4 carcinoma of the Prostate: 5-year followup, Phase II Southwest Oncology Group Study 9109.
• Prostate Cancer therapy.
• Incidental carcinoma of the Prostate: an analysis of the predictors of progression.
• Treatment of superficial papillary transitional cell carcinoma of the ureter by vesicoUreteral reflux of mitomycin C.
• Inflammatory pseudotumor (pseudosarcoma) of the Bladder.
• Examining the immune response in sentinel lymph nodes of mice and men.
• Surveillance versus nerve-sparing retroperitoneal lymphadenectomy in stage I nonseminomatous germ-cell tumors.
• Bilateral emphysematous pyelonephritis.
• Vasovasostomy in the mUrine vas deferens: comparison of the Nd:YAG laser at 1.06 microns and 1.318 microns to the CO2 laser.
• Bleeding ileal conduit stomal varices: diagnosis and management using transjugular transhepatic angiography and embolization.
• A rational approach to managing stage I nonseminomatous germ cell Cancer.
• Randomized intergroup comparison of bacillus calmette-guerin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the b...
• Tumour-induced polarization of tumour vaccine-draining lymph node T cells to a type 1 cytokine profile predicts inherent strong immunogenicity of the tumour and correl...
• Oral bropirimine immunotherapy of carcinoma in situ of the Bladder: results of a phase II trial.
• Paraneoplastic neurological syndrome in transitional cell carcinoma of the Bladder.
• Malignant transformation of angiomyolipoma.
• Preservation of the anterior urethral ligamentous attachments in maintaining post-Prostatectomy urinary continence: a comparative study.
• Endoscopic topical placement of formalin soaked pledgets to control localized hemorrhage due to radiation cystitis.
• Penile stump advancement as an alternative to perineal urethrostomy after Penile amputation.
• Prostatic occurrence of transitional cell carcinoma after intravesical chemotherapy.
• Comparison of Bladder neck preservation to Bladder neck resection in maintaining postrostatectomy urinary continence.
• Management of stage T1a prostate Cancer.
• Fatal sepsis following intravesical bacillus Calmette-Guerin administration for Bladder cancer.
• Management of stage A prostate Cancer with a high probability of progression.
• Evaluation of menogaril in Renal cell carcinoma. A Southwest Oncology Group phase II study (8504).
• Prognostic significance of DNA ploidy in Ta/Tl Bladder cancer: A southwest oncology group study.
• The prognostic significance of S-phase analysis in stage Ta/T1 Bladder cancer. A Southwest Oncology Group Study.
• A randomized comparison of cisplatin alone or in combination with methotrexate, vinblastine, and doxorubicin in patients with metastatic urothelial carcinoma: a cooper...
• Bilateral orchiectomy with or without flutamide for metastatic prostate Cancer.
• The predictive accuracy of staging transurethral resection of the prostate in the management of stage A Cancer of the prostate: a comparative evaluation.
• Maintenance bacillus Calmette-Guerin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the Bladder: a randomized Southwest Oncolo...
• Combination transurethral resection, systemic chemotherapy, and pelvic radiotherapy for invasive (T2-T4) Bladder cancer unsuitable for cystectomy: a phase I/II Southwe...
• Neoadjuvant hormonal therapy and radical Prostatectomy for clinical stage C carcinoma of the Prostate.
• Polymorphisms of GSTP1 and related genes and prostate Cancer risk.
• Association of codon 72 polymorphism of p53 with lower prostate Cancer risk.
• Analysis of risk factors associated with prostate Cancer extension to the surgical margin and pelvic node metastasis at radical prostatectomy.
• Disease recurrence and progression in untreated pathologic stage T3 prostate Cancer: selecting the patient for adjuvant therapy.
• A phase II trial of interferon-alpha and 5-fluorouracil in patients with advanced Renal cell carcinoma. A Southwest Oncology Group study.
• Phase II trial of bicalutamide in patients with advanced prostate Cancer in whom conventional hormonal therapy failed: a Southwest Oncology Group study (SWOG 9235).
• Phase II study of weekly docetaxel in symptomatic androgen-independent prostate Cancer.
• Weekly high-dose calcitriol and docetaxel in advanced prostate Cancer.

Schools

---

• Univ Of Ks Sch Of Med

• Vanderbilt University

Procedures Preformed

---

• AdRenalectomy
• AdRenalectomy With Robotic Assistance
• Complete Nephrectomy With Robotic Assistance
• Cystectomy
• View All

Conditions Treated

---

• Atrophic Vaginitis
• Balanoposthitis
• Bladder Cancer
• Bladder Infection
• View All

Doctors Specialties

---

• Urology

Accepted Insurances

---

Awards

---

• Portland Monthly Magazine
• Top MD

Education

---

• Vanderbilt University
• University of Kansas School of Medicine

Hospital

---

• Providence St. Vincent Medical Center

Drug Facts

---

NPI NUMBER		1407881493
NPPES Provider LastName		LOWE
NPPES Provider FirstName		BRUCE
NPPES Provider ZIPCode		97210
NPPES Provider State		OR
Specialty Description		Urology
Total Claim Count		357.0
Distinct Opioid Count		1.0
Opioid Claim Count		27.0
Percent Opioid Claims		7.56

Helpful Reviews

---

Give Anonymous Review

Medicare Facts

---

National Provider Identifier [NPI]	1407881493
Last Name Of The Provider	LOWE
First Name Of The Provider	BRUCE
View All

Similar Doctors

---

	Dr. Robert J. Moore, MD
	Dr. Robert E. Barham, MD This Doctor is OpenDoctor Recommended.
	Dr. Stanley A. Myers, MD This Doctor is OpenDoctor Recommended.
	Dr. Jeffrey C. La Rochelle, MD This Doctor is OpenDoctor Recommended.
	Dr. Lesley Nicoloff Otto, MD
	Dr. Roger A. Wicklund, MD This Doctor is OpenDoctor Recommended.
	Dr. Sarah L. Hecht, MD
	Dr. Amanda G. VanDlac, MD
	Dr. Rajeev Madala, MD This Doctor is OpenDoctor Recommended.

---

Doctor Directory | TOS | twitter | FB | Angel | blog